EcoDrugPlus

Cyclin Dependent Kinase 4

Ensembl ID : ENSKMAG00000016842
Gene Symbol: CDK4
3 Cross references
238 Possible Orthologues:

Cyclin Dependent Kinase 5

Ensembl ID : ENSKMAG00000004590
Gene Symbol: CDK5
3 Cross references
169 Possible Orthologues:

Cyclin Dependent Kinase 6

Ensembl ID : ENSKMAG00000001123
Gene Symbol: CDK6
3 Cross references
200 Possible Orthologues:

Cyclin Dependent Kinase 7

Ensembl ID : ENSKMAG00000013003
Gene Symbol: CDK7
3 Cross references
218 Possible Orthologues:

Cyclin Dependent Kinase 9

Ensembl ID : ENSKMAG00000005661
Gene Symbol: CDK9
3 Cross references
207 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSKMAG00000015292
Gene Symbol: CYSLTR1
3 Cross references
176 Possible Orthologues:

Cytidine Deaminase-Like

Ensembl ID : ENSKMAG00000005318
Gene Symbol: LOC108246855
3 Cross references
200 Possible Orthologues:

Cytochrome P450 26a1

Ensembl ID : ENSKMAG00000006451
Gene Symbol: LOC108245157
3 Cross references
194 Possible Orthologues:

Cytochrome P450 3a30

Ensembl ID : ENSKMAG00000007943
Gene Symbol: LOC108244157
3 Cross references
547 Possible Orthologues:

Cytochrome P450 3a40-Like

Ensembl ID : ENSKMAG00000017055
Gene Symbol: LOC108244648
3 Cross references
536 Possible Orthologues:

Cytochrome P450 Family 19 Subfamily A Member 1

Ensembl ID : ENSKMAG00000021603
Gene Symbol: CYP19A1
4 Cross references
244 Possible Orthologues:

Delta-Type Opioid Receptor-Like

Ensembl ID : ENSKMAG00000013296
Gene Symbol: LOC108245960
3 Cross references
179 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).